July 10, 2020

The Niche

Knoepfler lab stem cell blog

Dr. John Steeves Professor at UBC

6 min read

Recently I had the opportunity to talk with the leadership of Asterias, a California biotech doing exciting clinical research using stem cells as the basis for treatment of spinal cord injury. The interview covers the past (Geron patients), present, and future. I spoke with Asterias President and CEO Stephen Cartt and CMO Edward Wirth. How are the Geron patients doing? Asterias: They are doing well. We have to remember that they got the low dose (2 million OPC1 cells) and we estimated that an …Read More